Acasti Pharma Inc. Class A - ADR Financials

$3.28

$-0.09 (-2.67%)

As on 21-Nov-2024 09:30EDT

Market cap

$34 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Cash From Operating Activities	--	-12.33	-15.91	-17.23	-14.32	-22.94
Cash Flow from Investing Activities	--	--	--	-3.52	-9.86	8.14
Cash from Financing Activities	--	7.36	0.30	34.68	59.49	13.18
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
ROCE (%)	--	-19.75	-47.94	-11.95	-57.13	-206.42
ROE (%)	-19.69	-19.82	-48.15	-11.98	-57.33	-219.69
ROA (%)	-15.72	-16.86	-40.85	-10.28	-46.13	-87.09
EBIT Margin (%)	--	--	--	-162,647.65	-6,750.40	--
Net Margin (%)	--	--	--	-75,530.77	-10,039.80	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Revenue Growth (%)	--	--	-1.00	-0.93	--	--
EBIT Growth (%)	-152.17	-171.95	174.36	-59.81	45.86	27.51
Net Profit Growth (%)	71.50	69.71	-332.11	50.10	23.61	41.27
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.59	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.56	2.04	-1.73	2.17	4.93	0.65
Close Price ($)	3.00	3.43	2.76	7.32	28.80	18.22
High Price ($)	3.59	3.84	8.10	32.64	58.56	147.84
Low Price ($)	1.98	1.72	2.04	5.58	8.21	12.00
Market Cap ($ Cr)	34.17	--	--	--	--	--

Solvency Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Debt to Equity	--	--	0.01	0.00	0.00	0.01
Short term debt to equity ratio	--	--	0.00	0.00	0.00	0.01
Current Ratio	6.01	14.26	8.59	13.97	39.50	2.17
Quick Ratio	6.01	--	--	--	--	2.03
Interest Coverage	-16.85	-12.42	0.23	-94.39	-50.12	-98.94

Operating Efficiency Ratios	TTM	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Feb-17	Mar-16
Debtors to sales (%)	--	--	--	4,215.38	270.41	--
Asset Turnover	--	--	--	0.00	0.00	--
Receivable days	--	--	--	15,143.83	1,002.57	--
Inventory Days	--	--	--	--	5,276.90	162.72
Payable days	--	37,338.51	10.22	21.00	4,392.61	374.44
Cash Conversion Cycle	--	--	--	--	1,886.86	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.